Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 631

1.

The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.

El-Koofy NM, Anwar GM, El-Raziky MS, El-Hennawy AM, El-Mougy FM, El-Karaksy HM, Hassanin FM, Helmy HM.

Saudi J Gastroenterol. 2012 Jan-Feb;18(1):44-9. doi: 10.4103/1319-3767.91738.

2.

Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents.

Cardoso AS, Gonzaga NC, Medeiros CC, Carvalho DF.

J Pediatr (Rio J). 2013 Jul-Aug;89(4):412-8. doi: 10.1016/j.jped.2012.12.008.

3.

The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.

El-Karaksy HM, El-Raziky MS, Fouad HM, Anwar GM, El-Mougy FM, El-Koofy NM, El-Hennawy AM.

Diabetes Metab Syndr. 2015 Apr-Jun;9(2):114-9. doi: 10.1016/j.dsx.2013.10.008.

PMID:
25470627
4.

Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.

Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V.

Int J Obes (Lond). 2008 Feb;32(2):381-7.

PMID:
18087267
5.

Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.

Kodhelaj K, Resuli B, Petrela E, Malaj V, Jaze H.

Minerva Pediatr. 2014 Feb;66(1):23-30.

PMID:
24608579
6.

Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.

Alkassabany YM, Farghaly AG, El-Ghitany EM.

Arab J Gastroenterol. 2014 Jun;15(2):76-81. doi: 10.1016/j.ajg.2014.05.002.

PMID:
25097051
7.

Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.

Yoo J, Lee S, Kim K, Yoo S, Sung E, Yim J.

Diabetes Res Clin Pract. 2008 Sep;81(3):321-6. doi: 10.1016/j.diabres.2008.05.006.

PMID:
18571268
8.

[Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].

Graffigna MN, Belli SH, de Larrañaga G, Fainboim H, Estepo C, Peres S, García N, Levalle O.

Acta Gastroenterol Latinoam. 2009 Mar;39(1):30-7. Spanish.

PMID:
19408737
9.

Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome.

Calcaterra V, Muratori T, Klersy C, Albertini R, Caramagna C, Brizzi V, Larizza D.

Ann Nutr Metab. 2011 Oct;58(4):307-14. doi: 10.1159/000331573.

PMID:
21912108
10.

[Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].

Shi HB, Fu JF, Liang L, Wang CL, Zhu JF, Zhou F, Zhao ZY.

Zhonghua Er Ke Za Zhi. 2009 Feb;47(2):114-8. Chinese.

PMID:
19573457
11.

Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.

Bhat G, Baba CS, Pandey A, Kumari N, Choudhuri G.

Trop Gastroenterol. 2013 Jan-Mar;34(1):18-24.

12.

The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West.

Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A, Kalra N.

Dig Dis Sci. 2007 Sep;52(9):2368-74.

PMID:
17420951
13.

The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children.

Gupta R, Bhangoo A, Matthews NA, Anhalt H, Matta Y, Lamichhane B, Malik S, Narwal S, Wetzler G, Ten S.

J Pediatr Endocrinol Metab. 2011;24(11-12):907-11.

PMID:
22308841
14.

Metabolic syndrome risk factors in overweight, obese, and extremely obese Brazilian adolescents.

Rizzo AC, Goldberg TB, Silva CC, Kurokawa CS, Nunes HR, Corrente JE.

Nutr J. 2013 Jan 30;12:19. doi: 10.1186/1475-2891-12-19.

15.

[Metabolic syndrome in overweight and obese schoolchildren in Beijing].

Wan NJ, Mi J, Wang TY, Duan JL, Li M, Gong CX, Du JB, Zhao XY, Cheng H, Hou DQ, Wang L.

Zhonghua Er Ke Za Zhi. 2007 Jun;45(6):417-21. Chinese.

PMID:
17880785
16.

Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.

Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva AP, Makaya M, Mizoue T, Kato N, Wickremasinghe AR, de Silva HJ.

J Gastroenterol Hepatol. 2009 Jul;24(7):1284-8. doi: 10.1111/j.1440-1746.2009.05831.x.

PMID:
19476560
17.

Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease.

Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S.

Circulation. 2008 Jul 15;118(3):277-83. doi: 10.1161/CIRCULATIONAHA.107.739920.

18.

Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.

Huang SC, Yang YJ.

J Pediatr Gastroenterol Nutr. 2013 Feb;56(2):145-50. doi: 10.1097/MPG.0b013e3182722aee.

PMID:
22983378
19.

Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease.

Chen ZW, Chen LY, Dai HL, Chen JH, Fang LZ.

J Zhejiang Univ Sci B. 2008 Aug;9(8):616-22. doi: 10.1631/jzus.B0720016.

20.

Prevalence and predictors of alanine aminotransferase elevation among normal weight, overweight and obese youth in Mexico.

Purcell M, Flores YN, Zhang ZF, Denova-Gutiérrez E, Salmeron J.

J Dig Dis. 2013 Sep;14(9):491-9. doi: 10.1111/1751-2980.12072.

PMID:
23678860

Supplemental Content

Support Center